Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2012 on January 24

Updated

Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2012 on January 24

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYS: BMY) will announce results for the fourth quarter and full year of 2012 on Thursday, January 24, 2013. During a conference call at 10:30 a.m. ET on January 24, company executives will review financial information and will address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing 913-981-5581, confirmation code: 8041448. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 2 p.m. ET on January 24 through midnight ET on February 7, 2013. The replay will also be available through http://investor.bms.com or by dialing 402-280-9013, confirmation code: 8041448.


About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

anImage
anImage



Bristol-Myers Squibb Company
Media:
Jennifer Fron Mauer, 609-252-6579
jennifer.mauer@bms.com
or
Investors:
John Elicker, 609-252-4611
john.elicker@bms.com

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS:

The article Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2012 on January 24 originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement